BioSpace News Archive

Skyhawk will use its SkySTAR™ platform to develop drug candidates directed to multiple targets for neurodegenerative diseases. In exchange Takeda will pay Skyhawk an upfront payment, future milestone payments and royalties.

Putting knowledge and buying power to work for Canadian healthcare

Organizations Collaborate to Deliver Nationwide Campaign During National Bladder Cancer Awareness Month

BIO-LIBRA Study Aims to Break the Tradition of Underrepresentation of Women in Heart Disease Studies

Research on Subcutaneous Immunoglobulin Reports Zero Serious Bacterial Infections

Results highlighting consistent patterns in efficacy across multiple outcomes measures presented at International Society for Autism Research Annual Meeting in Montreal.

First Enzyme Substitution Therapy Approved in Europe to Treat the Underlying Cause of PKU in Patients Aged 16 Years or Older at Doses up to 60 mg

“My son was in a near-fatal accident, leaving him paralyzed in his right arm,” said an inventor from Wharton, N.J. “He is also a type 1 diabetic. I invented this so that he can change his insulin pump cartridge by himself.”

CreakyJoints® and ArthritisPower® data published in ACR Open Rheumatology

Surgical Notes, a nationwide provider of revenue cycle services and solutions for the ambulatory surgery center (ASC) and surgical hospital markets, announces it has entered into a partnership with Casetabs, a cloud-based surgery coordination app that facilitates practice to facility case scheduling, anesthesia coordination, implant vendor management, and live case team updates.